A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
This content was published on Oct 24, 2024 On Thursday, the Swiss Federal Railways presented its first fully renovated InterCity tilting train (ICN). Read more: Swiss railways presents first fully ...
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National ...
The FDA has recalled thousands of bottles of the antidepressant duloxetine, sold under brand name Cymbalta, due to the ...
The Food and Drug Administration (FDA) has recalled over 7,000 bottles of the popular antidepressant duloxetine – sold under ...
The FDA recalled more than 7,000 bottles of an antidepressant due to the presence of a carcinogenic chemical. The ...
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant duloxetine over the presence of ...
The recall was initiated due to the discovery of N-nitroso-duloxetine, a chemical impurity classified as a nitrosamine.
The FDA's recall involves 7,107 bottles containing 500 delayed-release 20 milligram duloxetine capsules, which are prescribed to treat conditions such as anxiety, depression, nerve pain related to ...
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...